Abstract
Purpose. The effects of transfection with the human Cu, Zn-superoxide dismutase (hSOD)4 gene on active oxygen-induced cytotoxicity in rat skin fibroblasts (FR) were studied for the purpose of developing the novel delivery system of hSOD using hSOD gene.
Methods. An expression plasmid for hSOD, pRc/RSV-SOD, was constructed and used to transfect FR cells. Xanthine (X)/xanthine oxidase (XO) system were used to generate active oxygen species. The effects of transfection with the hSOD gene on active oxygen-induced cytotoxicity were assessed by comparing the number of surviving cells and the level of lipid peroxidation in host and transformants after exposure to X/XO system.
Results. The cellular SOD activity in RSV-SOD cells transfected with pRc/RSV-SOD was significantly increased in comparison with host or RSV cells transfected with the pRc/RSV plasmid containing no hSOD gene as a control. Furthermore, Western blot analysis using an anti-hSOD antibody indicated the production of hSOD in RSV-SOD cells. On the other hand, although the numbers of surviving cells in both host and RSV-SOD cultures after exposure to X/XO system decreased in a time-dependent manner, the decrease in number of surviving RSV-SOD cells was less than that in host cells. In the presence of catalase, the decreases in number of surviving cells in both host and RSV-SOD cultures after exposure to the X/XO system were also less than those in the absence of catalase. However, the decreases in cell survival in RSV-SOD cultures were significantly less than those in host cells in the presence of catalase. Furthermore, the levels of lipid peroxidation in RSV-SOD cells exposed to the X/XO system in the presence or absence of catalase were lower than those in host cells. These results indicated that the increase in cellular SOD activity by transfection with the hSOD gene protects cells from oxidative stress.
Conclusions. Human SOD gene therapy may be useful for treatment of diseases in which oxidative tissue damage is produced.
Similar content being viewed by others
REFERENCES
C. E. Cross, B. Halliwell, E. T. Borish, W. A. Pryor, B. N. Ames, R. L. Saul, J. M. McCord, and D. Massaro. Oxygen radicals and human disease. Ann. Intern. Med. 107:526–545 (1987).
C. G. Cochrane, R. Spragg, and S. D. Revak. Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid. J. Clin. Invest. 71:754–761 (1983).
I. Fridovich. Superoxide dismutase. J. Biol. Chem. 264:7761–7764 (1989).
H. Hiraishi, A. Terano, T. Sugimoto, T. Harada, M. Razandi, and K. J. Ivey. Protective role of intracellular superoxide dismutase against extracellular oxidants in cultured rat gastric cells. J. Clin. Invest. 93:331–338 (1994).
B. A. Markey, S. H. Phan, J. Varani, U. S. Ryan, and P. A. Ward. Inhibition of cytotoxicity by intracellular superoxide dismutase supplementation. Free Radicals Biol. Med. 9:307–314 (1990).
Y. Kiyohara, K. Nishiguchi, F. Komada, S. Iwakawa, M. Hirai, and K. Okumura. Cytoprotective effects of epidermal growth factor (EGF) ointment containing protease inhibitor, nafamostat, on tissue damage at burn sites in rats. Biol. Pharm. Bull. 16:1146–1149 (1993).
K. Nishiguchi, Y. Kiyohara, F. Komada, S. Iwakawa, and K. Okumura. Effect of epidermal growth factor on Cu, Zn-superoxide dismutase expression in cultured fibroblasts from rat skin. Pharm. Res. 11:1244–1249 (1994).
T. Ogino, M. Inoue, Y. Ando, A. Awai, H. Maeda, and Y. Morino. Chemical modification of superoxide dismutase: Extension of plasma half life of the enzyme through its reversible binding to the circulating albumin. Int. J. Pept. Protein Res. 32:153–159 (1988).
P. S. Pyatak, A. Abuchowski, and F. F. Davis. Preparation of a polyethylene glycol: superoxide dismutase adduct, and an examination of its blood circulation life and anti-inflammatory activity. Res. Commun. Chem. Pathol. Pharmacol. 29:113–127 (1980).
C. H. Evans, and P. D. Robbins. Gene therapy for Arthritis. In J. A. Wolff (eds.), Gene Therapeutics: Methods and Applications of Direct Gene Transfer, Birkhäuser, Boston, 1994, pp. 320–343.
P. L. Felgner, T. R. Gadek, M. Holm, R. Roman, H. W. Chan, M. Wenz, J. P. Northrop, G. M. Ringold, and M. Danielsen. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84:7413–7417 (1987).
I. Fridovich. Quantitative aspects of the production of superoxide anion radical by milk xanthine oxidase. J. Biol. Chem. 245:4053–4057 (1970).
K. Yagi. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem. Med. 15:212–216 (1976).
I. S. Ayene, C. Dodia, and A. B. Fisher. Role of oxygen in oxidation of lipid and protein during ischemia/reperfusion in isolated perfused rat lung. Arch. Biochem. Biophys. 296:183–189 (1992).
K. Okumura, Y. Kiyohara, F. Komada, S. Iwakawa, M. Hirai, and T. Fuwa. Improvement in wound healing by epidermal growth factor (EGF) ointment I. Effect of nafamostat, gabexate, or gelatin on stabilization and efficacy of EGF. Pharm. Res. 7:1289–1293 (1990).
Y. Kiyohara, F. Komada, S. Iwakawa, M. Hirai, T. Fuwa, and K. Okumura. Improvement in wound healing by epidermal growth factor (EGF) ointment II: Effect of protease inhibitor, nafamostat, on stabilization and efficacy of EGF in burn. J. Pharmacobio-Dyn. 14:47–52 (1991).
R. H. Simon, C. H. Scoggin, and D. Patterson. Hydrogen peroxide causes the fatal injury to human fibroblasts exposed to oxygen radicals. J. Biol. Chem. 256:7181–7186 (1981).
P. Amstad, A. Peskin, G. Shah, M. E. Mirault, R. Moret, I. Zbinden, and P. Cerutti. The balance between Cu, Zn-superoxide dismutase and catalase affects the sensitivity of mouse epidermal cells to oxidative stress. Biochemistry 30:9305–9313 (1991).
M. J. Goebel, N. Rudolph, and S. L. Wong. Developmental patterns of antioxidant defense mechanisms in human erythrocytes. Pediatr. Res. 26:366–369 (1989).
M. J. Speranza, A. C. Bagley, and R. E. Lynch. Cells enriched for catalase are sensitized to the toxicities of bleomycin, adriamycin, and paraquat. J. Biol. Chem. 268:19039–19043 (1993).
B. Halliwell, and J. M. C. Gutteridge. The importance of free radicals and catalytic metal ions in human diseases. Mol. Aspects Med. 8:89–193 (1985).
D. R. Rosen, T. Siddique, D. Patterson, D. A. Figlewicz, P. Sapp, A. Hentati, D. Donaldson, J. Goto, J. P. O'Regan, H.-X. Deng, Z. Rahmani, A. Krizus, D. Mck.-Yasek, A. Cayabyab, S. M. Gaston, R. Berger, R. E. Tanzi, J. J. Halperin, B. Herzfeldt, R. V. B. Bergh, W.-Y. Hung, T. Bird, G. Deng, D. W. Mulder, C. Smyth, N. G. Laing, E. Soriano, M. A. Pericak-Vance, J. Haines, G. A. Rouleau, J. S. Gusella, H. R. Horvitz and R. H. Brown, Jr. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59–62 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nishiguchi, K., Ishida, K., Nakajima, M. et al. Effects of Transfection with the Cu, Zn-Superoxide Dismutase Gene on Xanthine/Xanthine Oxidase-Induced Cytotoxicity in Fibroblasts from Rat Skin. Pharm Res 13, 577–582 (1996). https://doi.org/10.1023/A:1016050205854
Issue Date:
DOI: https://doi.org/10.1023/A:1016050205854